跳至主要内容
临床试验/IRCT20200418047116N1
IRCT20200418047116N1招募中2 期

Effect of Intravenous immunoglobulin (IVIG) versus Kaletra (lopinavir and ritonavir) tablets in patients with acute respiratory infection (COVID-19): A clinical trial studies

Gonabad University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Positive PCR for COVID -19
  • Informed consent for inclusion
  • Hypoxemia not responsive to oxygen therapy
  • Loss of consciousness (GCS<=14)
  • Hemodynamic instability
  • Hypercapnia
  • Extent of pulmonary involvement
  • Non-use estrogen-containing compounds
  • Non-be pregnant or breastfeeding

排除标准

  • Sensitivity to IVIG
  • IgA deficiency history
  • Allergic reaction during IVIG injection

研究者

发起方
Gonabad University of Medical Sciences

相似试验